PICO Portalanswers from OpenAlex & ORCID
Florence I. Raynaud
ResearcherPublications, citations & collaboration network
Florence I. Raynaud is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Florence I. Raynaud have?
PICO Portalindexed works
Florence I. Raynaud has 721 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Florence I. Raynaud have?
PICO Portalcitation count
Florence I. Raynaud has 18,299 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Florence I. Raynaud?
PICO Portalh-index
Florence I. Raynaud has an h-index of 75 in OpenAlex.
What is the i10-index of Florence I. Raynaud?
PICO Portali10-index
Florence I. Raynaud has an i10-index of 181 in OpenAlex.
What is the ORCID of Florence I. Raynaud?
PICO Portalorcid
The ORCID for Florence I. Raynaud is on the source record.
What is the OpenAlex record for Florence I. Raynaud?
PICO Portalopenalex
The OpenAlex for Florence I. Raynaud is on the source record.
What are the most-cited papers on Florence I. Raynaud?
PICO Portalmost cited works
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
Gerhardt Attard, Alison Reid, Timothy A. Yap, Florence I. Raynaud, Mitch Dowsett, S. Settatree, Mary Barrett, Christopher Parker, Vanessa Martins, Elizabeth Folkerd, Jeremy Clark, Colin S. Cooper, Stan B. Kaye, David P. Dearnaley, Gloria Lee, Johann S. de Bono
Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies
Udai Banerji, Anne O’Donnell, Michelle Scurr, Simon Pacey, Sarah Stapleton, Yasmin J. Asad, Laura K. Simmons, Alison Maloney, Florence I. Raynaud, Maeli Campbell, Michael I. Walton, Sunil R. Lakhani, Stanley B. Kaye, Paul Workman, Ian Judson
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
Debashis Sarker, Joo Ern Ang, Richard D. Baird, Rebecca Kristeleit, Krunal Shah, Víctor Moreno, Paul A. Clarke, Florence I. Raynaud, Gallia G. Levy, Joseph A. Ware, Kathryn Mazina, Ray Lin, Jenny Wu, Jill Fredrickson, Jill M. Spoerke, Mark R. Lackner, Yibing Yan, Lori S. Friedman, Stan B. Kaye, Mika K. Derynck, Paul Workman, Johann S. de Bono